Chitosan-dextran sulphate nanocapsule drug delivery system as an effective therapeutic against intraphagosomal pathogen Salmonella

Journal of Antimicrobial Chemotherapy

Volumn 68, Issue 11, 2013, Pages 2576-2586

  Gnanadhas, Divya Prakash ^a   Ben Thomas, Midhun ^a   Elango, Monalisha ^a   Raichur, Ashok M ^a,b   Chakravortty, Dipshikha ^a  

^a INDIAN INSTITUTE OF SCIENCE   (India)

^b UNIVERSITY OF JOHANNESBURG   (South Africa)

Author keywords

Ciprofloxacin ceftriaxone gentamicin; Intravacuolar pathogens; Layer by layer (lbl); Polyelectrolyte capsules; Typhoid

Indexed keywords

CEFTRIAXONE; CHITOSAN; CIPROFLOXACIN; DEXTRAN SULFATE; GENTAMICIN; NANOCAPSULE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL LOAD; CELL PROLIFERATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY; DRUG CLEARANCE; DRUG COST; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG RELEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MEDICATION COMPLIANCE; MOUSE; NONHUMAN; RECOMMENDED DRUG DOSE; SALMONELLOSIS; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY; TREATMENT DURATION; ZETA POTENTIAL;

CIPROFLOXACIN/CEFTRIAXONE/GENTAMICIN; INTRAVACUOLAR PATHOGENS; LAYER-BY-LAYER (LBL); POLYELECTROLYTE CAPSULES; TYPHOID;

ANIMALS; ANTI-BACTERIAL AGENTS; CELL LINE; CHITOSAN; CIPROFLOXACIN; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; EPITHELIAL CELLS; MACROPHAGES; MICE; MICE, INBRED BALB C; NANOCAPSULES; PHAGOSOMES; SALMONELLA; SALMONELLA INFECTIONS, ANIMAL; TREATMENT OUTCOME;

EID: 84886299243     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkt252     Document Type: Article

References (43)

1. Briones E, Colino CI, Lanao JM. Delivery systemsto increase the selectivity of antibiotics in phagocytic cells. J Control Release 2008; 125: 210-27.
2. Chiang CY, Schaaf HS. Management of drug-resistant tuberculosis. Int J Tuberc Lung Dis 2010; 14: 672-82.
3. Janbaz KH, Qadir MI, Ahmad B et al. Tuberculosis-burning issues: Multidrug resistance and HIV-coinfection. Crit Rev Microbiol 2012; 38: 267-75.
4. McAdam PR, Templeton KE, Edwards GF et al. Molecular tracing of the emergence, adaptation, and transmission of hospital-associated methicillin-resistant Staphylococcus aureus. Proc Natl Acad Sci USA 2012; 109: 9107-12.
5. Savard P, Gopinath R, ZhuWet al. First NDM-positive Salmonella sp. strain identified in the United States. Antimicrob Agents Chemother 2011; 55: 5957-8.
6. Goossens H. Antibiotic consumption and link to resistance. Clin Microbiol Infect 2009; 15 Suppl 3: 12-5.
7. Megraud F, Coenen S, Versporten A et al. Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption. Gut 2012; 62: 34-42.
8. Lahiri A, Iyer N, Das P et al. Visiting the cell biology of Salmonella infection. Microbes Infect 2010; 12: 809-18.
9. Marathe SA, Lahiri A, Negi VD et al. Typhoid fever and vaccine development: a partially answered question. Indian J Med Res 2012; 135: 161-9.
10. Nogrady N, Kiraly M, Davies R et al. Multidrug resistant clones of Salmonella Infantis of broiler origin in Europe. Int J Food Microbiol 2012; 157: 108-12.
11. Thai TH, Hirai T, Lan NTet al. Antibiotic resistance profiles of Salmonella serovars isolated from retail pork and chicken meat in North Vietnam. Int J Food Microbiol 2012; 156: 147-51.
12. Donath E, Moya S, Neu B et al. Hollow polymer shells from biological templates: fabrication and potential applications. Chemistry-A European Journal 2002; 8: 5481-5.
13. Sukhorukov GB. Designed nano-engineered polymer films on colloidal particles and capsules. In: Möbius D, Miller R, eds. Studies in Interface Science. Amsterdam: Elsevier, 2001; 383-414.
14. Sukhorukov GB, Donath E, Davis S et al. Stepwise polyelectrolyte assembly on particle surfaces: a novel approach to colloid design. Polymers for Advanced Technologies 1998; 9: 759-67.
15. Akagi T, Ueno M, Hiraishi K et al. AIDS vaccine: intranasal immunization using inactivated HIV-1-capturing core-corona type polymeric nanospheres. J Controlled Release 2005; 109: 49-61.
16. Matsusaki M, Hiwatari K-i, Higashi M et al. Stably-dispersed and surfacefunctional bionanoparticles prepared by self-assembling amphipathic polymers of hydrophilic poly(g-glutamic acid) bearing hydrophobic amino acids. Chemistry Letters 2004; 33: 398-9.
17. Jin Y, Liu W, Wang J et al. (Protamine/dextran sulfate)6 microcapsules templated on biocompatible calcium carbonate microspheres. Colloids Surf A Physicochem Eng Asp 2009; 342: 40-5.
18. Mauser T, Dejugnat C, Mohwald H et al. Microcapsules made of weak polyelectrolytes: templating and stimuli-responsive properties. Langmuir 2006; 22: 5888-93.
19. Salaün F, VromanI. Influence of corematerials on thermal properties of melamine-formaldehyde microcapsules. European Polymer J 2008; 44: 849-60.
20. Decher G. Fuzzy nanoassemblies: toward layered polymeric multicomposites. Science 1997; 277: 1232-7.
21. An Z, Möhwald H, Li J. pH Controlled permeability of lipid/protein biomimetic microcapsules. Biomacromolecules 2006; 7: 580-5.
22. Tong W, Gao C, Möhwald H. Stable weak polyelectrolyte microcapsules with pH-responsive permeability. Macromolecules 2005; 39: 335-40.
23. Okamoto Y, Minami S, Matsuhashi A et al. Polymeric N-acetyl-D-glucosamine (chitin) induces histionic activation in dogs. J Vet Med Sci 1993; 55: 739-42.
24. Tanigawa YT, Sashiwa H, Saimoto Y et al. Various biological effects of chitin derivatives. Princeton, NJ: Elsevier Applied Sciences, 1992.
25. Tokura S, Ueno K, Miyazaki S et al. Molecular weight dependent antimicrobial activity by chitosan. Macromol Symp 1997; 120: 1-9.
26. Nagahama H, Maeda H, Kashiki Tet al. Preparation and characterization of novel chitosan/gelatinmembranes using chitosan hydrogel. Carbohydrate Polymers 2009; 76: 255-60.
27. Baba M, Pauwels R, Balzarini J et al. Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro. Proc Natl Acad Sci USA 1988; 85: 6132-6.
28. Mitra S,GaurU,Ghosh PCet al. Tumour targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrier. J Control Release 2001; 74: 317-23.
29. CrumNF. Current trends in typhoid Fever. Curr Gastroenterol Rep 2003;5: 279-86.
30. Griffin AJ, Li LX, Voedisch S et al. Dissemination of persistent intestinal bacteria via the mesenteric lymph nodes causes typhoid relapse. Infect Immun 2011; 79: 1479-88.
31. Le Hello S, Hendriksen RS, Doublet B et al. International spread of an epidemic population of Salmonella enterica serotype Kentucky ST198 resistant to ciprofloxacin. J Infect Dis 2011; 204: 675-84.
32. Medalla F, Sjolund-Karlsson M, Shin S et al. Ciprofloxacin-resistant Salmonella enterica Serotype Typhi, United States, 1999-2008. Emerg Infect Dis 2011; 17: 1095-8.
33. Harish BN, Menezes GA, Sarangapani K et al. A case report and review of the literature: ciprofloxacin resistant Salmonella enterica serovar Typhi in India. J Infect Dev Ctries 2008; 2: 324-7.
34. Ahmed AI, van der Heijden FM, van den Berkmortel H et al. A man who wanted to commit suicide by hanging himself: an adverse effect of ciprofloxacin. Gen Hosp Psychiatry 2011; 33: 82 e5-7.
35. Liang VY, Ghearing GR, Zivkovic SA. Carpal tunnel syndrome after ciprofloxacin-induced tendinitis. J Clin Neuromuscul Dis 2010; 11: 165-6.
36. Ranjan A, PothayeeN, SeleemMNet al. In vitro trafficking and efficacy of core-shell nanostructures for treating intracellular Salmonella infections. Antimicrob Agents Chemother 2009; 53: 3985-8.
37. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55-63.
38. Eswarappa SM, Panguluri KK, Hensel M et al. The yejABEF operon of Salmonella confers resistance to antimicrobial peptides and contributes to its virulence. Microbiology 2008; 154: 666-78.
39. Lulevich VV, Vinogradova OI. Effect of pH and salt on the stiffness of polyelectrolyte multilayer microcapsules. Langmuir 2004; 20: 2874-8.
40. LeBel M. Ciprofloxacin: chemistry, mechanism of action, resistance, antimicrobial spectrum, pharmacokinetics, clinical trials, and adverse reactions. Pharmacotherapy 1988; 8: 3-33.
41. Garai P, Gnanadhas DP, Chakravortty D. Salmonella enterica serovars Typhimurium and Typhi as model organisms: Revealing paradigm of host-pathogen interactions. Virulence 2012; 3: 377-88.
42. Gould IM, MacKenzie FM. Antibiotic exposure as a risk factor for emergence of resistance: the influence of concentration. J Appl Microbiol 2002; 92: 78S-84S.
43. Kansal S, Tandon R, Dwivedi P et al. Development of nanocapsules bearing doxorubicin for macrophage targeting through the phosphatidylserine ligand: a system for intervention in visceral leishmaniasis. J Antimicrob Chemother 2012; 67: 2650-60.